Guidelines & Advice

Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

15 Items

Acute Leukemia Provincial Plan

Document Status: Current
ID: GL-C50-34

Aug 2017

Complex Malignant Hematology Models of Care: Recommendations for Changes in the Roles and Composition of the Multidisciplinary Team and the Setting of Care to Improve Access for Patients in Ontario – March 2017

Document Status: Current
ID: GL-C50-31

Mar 2017

Follow-up After Primary Therapy for Endometrial Cancer

Document Status: Current
ID: 4-9
Version: 2

Jun 2017

Guidance on the Substitution of Systemic Therapy Agents

Document Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Guideline for Optimization of Surgical and Pathological Quality Performance for Radical Prostatectomy in Prostate Cancer Management

Document Status: Current
ID: 17-3
Version: 2

Oct 2017

Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Document Status: Current
ID: GL SCT-8

Oct 2017

Performance of Needle Biopsy of the Prostate for Men with Suspected or Established Prostate Cancer

Document Status: Current
Version: 1

Sep 2017

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2017

Document Status: Current
ID: pet 2017-1

Dec 2017

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2016

Document Status: Current
ID: 2016-2

Apr 2017

PET Imaging in Paraneoplastic Neurological Syndromes

Document Status: Current
ID: PET 18

May 2017

Primary Excision Margins and Sentinel Lymph Node Biopsy in Cutaneous Melanoma

Document Status: Current
ID: 8-2
Version: 2

Nov 2017

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Document Status: Current
ID: GL-C50-30

Feb 2017